1 / 28

Oxidation of Pyruvate to Acetyl-CoA

Oxidation of Pyruvate to Acetyl-CoA. Pyruvate formed in the cytosol transported into the mitochondrion Oxidatively decarboxylated to acetyl-CoA NADH produced, transferred to the respiratory chain. 1 mol glucose  2 mol NADH ~ 2 x 2,5 ATP Enzyme : Pyruvate Dehydrogenase complex

britain
Télécharger la présentation

Oxidation of Pyruvate to Acetyl-CoA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Oxidation of Pyruvate to Acetyl-CoA Pyruvate formed in the cytosol transported into the mitochondrion Oxidatively decarboxylated to acetyl-CoA NADH produced, transferred to the respiratory chain. • 1 mol glucose  2 mol NADH ~ 2 x 2,5 ATP • Enzyme : Pyruvate Dehydrogenase complex • Pyruvate dehydrogenase component inhibited by NADH and Acetyl-CoA. • Deficiency of B1 vitamin  beri-beri

  2. Pyruvate is decarboxylated by the pyruvate dehydrogenase component of the enzyme complex to a hydroxyethyl derivative of the thiazole ring of enzyme-bound thiamin diphosphate, which in turn reacts with oxidized lipoamide, the prosthetic group of dihydrolipoyl transacetylase, to form acetyl lipoamide (Figure 18–5). Acetyl lipoamide reacts with coenzyme A to form acetyl-CoA and reduced lipoamide. The reaction is completed when the reduced lipoamide is reoxidized by a flavoprotein, dihydrolipoyl dehydrogenase, containing FAD. Finally, the reduced flavoprotein is oxidized by NAD+ , which in turn transfers reducing equivalents to the respiratory chain. Pyruvate + NAD+ + CoA  Acetyl-CoA + NADH + H+ + CO2

  3. Pyruvate dehydrogenase

  4. Pyruvate Dehydrogenase Is Regulated by End-Product Inhibition & Covalent Modification Pyruvate dehydrogenase is inhibited by its products, acetyl-CoA and NADH. It is also regulated by phosphorylation by a kinase of three serine residues on the pyruvate dehydrogenase component of the multi enzyme complex, resulting in decreased activity and by dephosphorylation by a phosphatase that causes an increase in activity. The kinase is activated by increases in the [ATP]/[ADP], [acetyl-CoA]/[CoA], and [NADH]/[NAD+ ] ratios. Thus, pyruvatedehydrogenase, and therefore glycolysis, is inhibited both when there is adequate ATP available, and also when fatty acids are being oxidized.

  5. Glycogen: Glycogenesis & glycogenolysis • Energy storage as carbohydrate in the liver and muscle • In the liver up to 6 % w/w • In the muscle up to 4 % w/w • Fasting for 18 hours will depletes glycogen in the liver • In the muscle glycogen will never be depleted • Molecular mass up to 4 millions

  6. Glycogenesis • In the fed state, glycogen synthesis increase • Glucose 6P (some, not all)  G 1P (phosphoglucomutase) • G 1P with UTP  UDPG + PP (UDPG pyrophosphorylase) • PP  Pi drives the reaction to the right (pyrophosphatase) • UDPG + glycogenn  glycogenn+1 + UDP (Glycogen Synthase = GS) • UDP + ATP  UTP + ADP • Glycogen synthesis from glucose require two ATP

  7. Pathways of glycogenesis and of glycogenolysis in the liver.

  8. Amylo α(1-4) α(1-6) Transglucosidase)

  9. Pathways of glycogenesis and of glycogenolysis in the liver.

  10. Glycogenolysis During fasting(liver) or during contraction (muscle) • Glycogen cleavaged by phosphorylase and debranching enzymes • Glucose 1P ( G 1P ) and glucose are released • Phosphate Pi is required • In the liver : G 1P  G 6P (phosphogluco mutase) G 6P  G + Pi (glucose 6Pase) • In the muscle : G 1P  G 6P (phosphogluco mutase) G 6P enter glycolysis  ATP Glucose 6 Pase can only be found in the liver, intestine and kidney

  11. Amylo α(1-4) α(1-4) Glucantransferase

  12. Control of Glycogenolysis During fasting when blood glucose tend to decline, glucagon through protein G will activates adenylyl cyclase. Adenylyl cyclase catalyzes formation of cAMP from ATP. cAMP in turn activates cAMP Dependent Protein Kinase. Then it catalyzes Phosphorylase Kinase into PK-P

  13. Phosphorylase Kinase-P (active = a) will catalyzes Phosphorylase (b=inactive) to Phosphorylase-P (a). The Phosphorylase-P will split Glycogen. Glucose 1P released (require Pi). Glucose 6 phosphatase hydrolysis G 6P to G and Pi. Glucose enter the blood stream to stabilize blood Glucose.

  14. Epinephrine in muscle If you are startled epinephrine in muscle activates Adenylyl cyclase , catalyze ATP  cAMP cAMP Dependent PK  active. Phosphorylase kinase  active. Phosphorylase  active. Glycogen  G 1P.  G 6P  no G 6Pase in the muscle, G 6P  x G. G 6P  glycolysis  ATP Eye  Central N.S  Peripheral nerves  Synapses  Ca++ Ca/Calmodulin  phosphorylase kinase active etc.

  15. Role of Ca++ in glycogenolysis

  16. Glycogenesis Gycogen Synthase ( GS ) active form GS, and GS-P inactive form. Protein Kinase GS  GS-P ↑ GSK There are seven Protein kinase that control glycogenesis Ca++ / Calmodulin Dependent ( 1 phosphorylase kinase ) cAMP Dependent Protein kinase Glycogen Synthase Kinase (GSK) 3, 4 and 5

  17. Glycogenolysis in muscle increases several 100-fold at the onset of contraction; the same signal (increased cytosolic Ca2+ ion concentration) is responsible for initiation of both contraction and glycogenolysis. Muscle phosphorylase kinase, which activates glycogen phosphorylase, is a tetramer of four different subunits, α, β, γ, and δ. The α and βsubunits contain serine residues that are phosphorylated by cAMP-dependent protein kinase. The δ subunit is identical to the Ca2+ -binding protein calmodulin, and binds four Ca2+ . The binding of Ca2+ activates the catalytic site of the subunit even while the enzyme is in the dephosphorylated b state; the phosphorylated a form is only fully activated in the presence of high concentrations of Ca2+ .

  18. Protein Phosphatase-1 Protein Phosphatase-1 hydrolyzes protein-P to Protein Kinase and Pi . Enzymes - P : • Glycogen Synthase-P • Phosphorylase-P • Phosphorylase Kinase-P Protein Phosphatase-1 is inhibited by Inhibitor 1-P Inhibitor 1  Inhibitor 1-P its phosphorylation catalyzed by cAMP Dependent PK.

  19. The Control of Phosphorylase Differs between Liver & Muscle In the Liver: Inhibited by ATP G 6P Glucose In the muscle : Inhibited by: ATP G 6P Activated by 5’AMP

  20. Effect of Insulin: Phosphorylase is inhibited by glucose (in the liver) . Insulin inhibits Phosphorylase if G available. If glucose concentration increases G 6P follows, in turn it will activates glycogen synthase Insulin (+) GS-P  GS Protein phosphatase-1

  21. Epinephrine effects liver glycogenolysis • through : • 1.Its effects on glucagon released • 2.Beta-adrenergik receptor, in turn • cAMP formation etc. • 3.Alfa-adrenergic receptor • Inositol triphosphate (IP3),  Ca++ • exitfrom ER  Phosphorylase kinase  • phosphorylase etc. • ( The major mechanism of the three)

  22. Glycogen Storage Diseases Are Inherited Type Ia glycogenosis ( von Gierke's disease ). Deficiency : glucose-6 phosphatase Clinical features : Glycogen accumulation in liver and renal tubule cells, hypoglycemia; lactic acidemia; ketosis; hyperlipemia. Type V (Myophosphorlylase deficiency, McArdle's syndrome) Deficiency : Muscle phosphorylase Poor exercise tolerance; muscle glycogen abnormally high (2.5–4%); blood lactate very low after exercise

  23. Type VI (Hers' disease) Deficiency : Liver phosphorylase Clinical features: Hepatomegaly; accumulation of glycogen in liver; mild hypoglycemia; generally good prognosis Type VII (Tarui's disease) Deficiency : Muscle and erythrocyte phosphofructokinase 1 Clinical features: Poor exercise tolerance; muscle glycogen abnormally high (2.5–4%); blood lactate very low after exercise; also hemolytic anemia

More Related